Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 890839-11-9 | MDL No. : | MFCD28128120 |
Formula : | C16H23BO4 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | FJPXZQYGTLPYRT-UHFFFAOYSA-N |
M.W : | 290.16 | Pubchem ID : | 57871071 |
Synonyms : |
|
Num. heavy atoms : | 21 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.56 |
Num. rotatable bonds : | 4 |
Num. H-bond acceptors : | 4.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 83.59 |
TPSA : | 44.76 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -5.75 cm/s |
Log Po/w (iLOGP) : | 0.0 |
Log Po/w (XLOGP3) : | 3.27 |
Log Po/w (WLOGP) : | 2.26 |
Log Po/w (MLOGP) : | 1.78 |
Log Po/w (SILICOS-IT) : | 2.37 |
Consensus Log Po/w : | 1.94 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -3.65 |
Solubility : | 0.0655 mg/ml ; 0.000226 mol/l |
Class : | Soluble |
Log S (Ali) : | -3.88 |
Solubility : | 0.0379 mg/ml ; 0.00013 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -4.5 |
Solubility : | 0.00913 mg/ml ; 0.0000315 mol/l |
Class : | Moderately soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 0.0 |
Synthetic accessibility : | 3.53 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
70% | Stage #1: With lithium diisopropyl amide In tetrahydrofuran at -78℃; for 0.333333 h; Stage #2: at 0 - 20℃; for 1 h; |
b) Methyl 2-f4-(4,4,5,5-tetramethyl-1 ,3,2-dioxaborolan-2-vDphenvπpropanoate; To a solution of methyl [4-(4,4,5,5-tetramethyl-1 ,3,2-dioxaborolan-2-yl)phenyl]acetate (1.04 g, 3.78 mmol) in THF (6 mL) was added LDA (3.5 mL, 1.5M in THF) dropwise at -780C under argon. After stirring for 20 min, the reaction mixture was warmed up to 0 0C, MeI ( 3.22 g, 22.6 mmol) was added and the mixture was stirred for 1 h at room temperature. The reaction was quenched by adding HCI (2M solution) until pH~2. The mixture was extracted with EtOAc, concentrated and purified via combiflash to give the product as a white solid (0.77 g, 70percent). 1H-NMR (CDCI3) δ : 1.354 (12H, s), 1.517 (3H, d, J=7.2 Hz ), 3.667 (3H, s), 3.750 (1H1 m), 7.323 (2H,d, J=7.2 Hz), 7.796 (2H, d, J=7.2 Hz). |
[ 478375-42-7 ]
Methyl 2-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetate
Similarity: 0.97
[ 454185-98-9 ]
Methyl 2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetate
Similarity: 0.97
[ 1415960-54-1 ]
Methyl 2-(2-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetate
Similarity: 0.96
[ 1257213-52-7 ]
Ethyl 1-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)cyclopropanecarboxylate
Similarity: 0.95
[ 859169-20-3 ]
Ethyl 2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetate
Similarity: 0.95
[ 478375-42-7 ]
Methyl 2-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetate
Similarity: 0.97
[ 454185-98-9 ]
Methyl 2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetate
Similarity: 0.97
[ 1415960-54-1 ]
Methyl 2-(2-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetate
Similarity: 0.96
[ 1257213-52-7 ]
Ethyl 1-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)cyclopropanecarboxylate
Similarity: 0.95
[ 859169-20-3 ]
Ethyl 2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetate
Similarity: 0.95
[ 478375-42-7 ]
Methyl 2-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetate
Similarity: 0.97
[ 454185-98-9 ]
Methyl 2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetate
Similarity: 0.97
[ 1415960-54-1 ]
Methyl 2-(2-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetate
Similarity: 0.96
[ 1257213-52-7 ]
Ethyl 1-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)cyclopropanecarboxylate
Similarity: 0.95
[ 859169-20-3 ]
Ethyl 2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetate
Similarity: 0.95